Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
Authors
Keywords
Diabetes type 1, Children, T regulatory cells, Immunotherapy
Journal
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-01
DOI
10.1186/s12967-016-1090-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease
- (2015) Anke Theil et al. CYTOTHERAPY
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Hurdles in therapy with regulatory T cells
- (2015) Piotr Trzonkowski et al. Science Translational Medicine
- Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up
- (2014) Natalia Marek-Trzonkowska et al. CLINICAL IMMUNOLOGY
- The Serum IL-6 Profile and Treg/Th17 Peripheral Cell Populations in Patients with Type 1 Diabetes
- (2013) Monika Ryba-Stanisławowska et al. MEDIATORS OF INFLAMMATION
- Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers
- (2013) Andrea K Steck et al. PEDIATRIC DIABETES
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Administration of CD4+CD25highCD127- Regulatory T Cells Preserves -Cell Function in Type 1 Diabetes in Children
- (2012) N. Marek-Trzonkowska et al. DIABETES CARE
- The Time is Crucial for Ex Vivo Expansion of T Regulatory Cells for Therapy
- (2011) Natalia Marek et al. CELL TRANSPLANTATION
- Anti-TNF rescue CD4+Foxp3+ regulatory T cells in patients with type 1 diabetes from effects mediated by TNF
- (2011) Monika Ryba et al. CYTOKINE
- Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young
- (2011) A. K. Steck et al. DIABETES CARE
- Lower Frequency of CD62Lhighand Higher Frequency of TNFR2+Tregs Are Associated with Inflammatory Conditions in Type 1 Diabetic Patients
- (2011) Monika Ryba et al. MEDIATORS OF INFLAMMATION
- Detection of cell death in diabetes using differentially methylated circulating DNA
- (2011) E. M. Akirav et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025
- (2010) P. Jarosz-Chobot et al. DIABETOLOGIA
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of -Cell Function in Therapeutic Trials in Type 1 Diabetes
- (2008) C. J. Greenbaum et al. DIABETES CARE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started